1Ringnmn JM, Medina LD, Rodrignez Agudelo Y, et al. Current concepts of mild cognitive impairment and their applicability to persons at risk for familial Alzheimer's disease[J]. Curr Alzheimer, 2009,6(4) : 341-346.
2Petersen RC ,Smith GE ,Waring SC, et al. Mild cognitive impair- ment:clinical characterization and outcome[J]. Arch Neurol, 1999, 56 ( 3 ) : 303 -308.
3Haan MN,Wallaee R. Can dementia be prevented brain aging in a population-based context[J]. Annu Rev Public Health,2004,25 : 1-24.
4Bengt Winblad,Mario Fioravanti,Tomas Dolezal,et al. Therapeu- tic Use of Nieergoline[J]. Clin Drug Invest, 2008,28 (9) : 533-552.
5Mario Fioravanti, Leon Flieker. Nieergoline for dementia and other age associated forms of cognitive impairment. Cochrane Database System Rev,2001,4:CD003159.
